Zdrowie i gospodarka · 05/01/1999

FDA Releases Draft Guidance on Impurities in ANDA's

The Food and Drug Administration (FDA) has published a draft guidance document outlining recommendations for reporting impurities in drug products submitted in abbreviated new drug applications (ANDA's), covering both monograph and nonmonograph products.